Long-Term Use of Omeprazole: Effect on Haematological and Biochemical Parameters

Background: Long-term use of proton pump inhibitors (PPIs) is believed to have various potential adverse events. Omeprazole is a part of PPIs most commonly prescribed worldwide; it irreversibly binds to H+-K+ ATPase enzyme system in the gastric parietal cells to reduce secretion of H+ ions into the...

Full description

Bibliographic Details
Main Authors: Hadeel S. Al Ali, Azza Sajid Jabbar, Nadheerah F. Neamah, Nawal Khalil Ibrahim
Format: Article
Language:English
Published: Interna Publishing 2022-12-01
Series:Acta Medica Indonesiana
Subjects:
Online Access:https://actamedindones.org/index.php/ijim/article/view/2231
_version_ 1797955992275648512
author Hadeel S. Al Ali
Azza Sajid Jabbar
Nadheerah F. Neamah
Nawal Khalil Ibrahim
author_facet Hadeel S. Al Ali
Azza Sajid Jabbar
Nadheerah F. Neamah
Nawal Khalil Ibrahim
author_sort Hadeel S. Al Ali
collection DOAJ
description Background: Long-term use of proton pump inhibitors (PPIs) is believed to have various potential adverse events. Omeprazole is a part of PPIs most commonly prescribed worldwide; it irreversibly binds to H+-K+ ATPase enzyme system in the gastric parietal cells to reduce secretion of H+ ions into the lumen of stomach. The main objective of the current work is to assess the adverse effects of omeprazole medication on certain haematological and biochemical parameters in patients who were on treatment for one year and more. Methods: We conducted a comparative cross-sectional study between October 2021 and March 2022. A total of 90 participants of both sexes were enrolled in this study, aged between 25-58 years. The participants were categorized into two groups: 40 patients on long-term omeprazole medication (40 mg) as a patients group and 50 healthy subjects as a healthy group who did not use omeprazole. Complete blood count and biochemical parameters were measured for both groups. Results: Patients of a group 1 had remarkable significant reductions in the number of red blood cells (RBCs) (p<0.001) and the indices. Omeprazole elevated the cholesterol level (p<0.001) and triglyceride (p<0.001) as well as low-density lipoprotein (p<0.01). However, no impact was found with high-density lipoprotein (HDL) (p>0.05). Alkaline phosphatase (ALKP) (p<0.001) and aspartate aminotransferase (ASAT) (p<0.01) levels were elevated in long-term patients treated with omeprazole. In contrast, no significant change was found in the level of alanine aminotransferase (ALAT) (p>0.05). Creatinine level (p<0.001) and nitrogen blood urea (p<0.0001) were significantly increased in patients group treated with omeprazole medication. The results also showed that group 1 had a high significant decline in serum ferritin (p<0.0001), vitamin D3 (p<0.01) and calcium levels (p<0.001) than that of healthy group. Conclusion: Prolonged use of omeprazole might result in adverse effect on hematological profile, particularly RBCs and their indices leading to develop anemia in patients on this medication. Furthermore, it might result in disturbances in biochemical profile, levels of minerals and vitamins as consequences of affected absorption.
first_indexed 2024-04-10T23:41:49Z
format Article
id doaj.art-bca4b0745153449496f8cde59995987f
institution Directory Open Access Journal
issn 0125-9326
2338-2732
language English
last_indexed 2024-04-10T23:41:49Z
publishDate 2022-12-01
publisher Interna Publishing
record_format Article
series Acta Medica Indonesiana
spelling doaj.art-bca4b0745153449496f8cde59995987f2023-01-11T07:11:42ZengInterna PublishingActa Medica Indonesiana0125-93262338-27322022-12-01544551Long-Term Use of Omeprazole: Effect on Haematological and Biochemical ParametersHadeel S. Al Ali0Azza Sajid Jabbar1Nadheerah F. Neamah2Nawal Khalil Ibrahim3Department of Physiology, Al-Zahraa College of Medicine, University of Basrah, Basrah, IraqDepartment of Pharmacology and Toxicology, College of Pharmacy, University of Basrah, Basrah, IraqDepartment of Pharmacology and Toxicology, College of Pharmacy, University of Basrah, Basrah, IraqDepartment of Physiology, College of Medicine, University of Basrah, Basrah, IraqBackground: Long-term use of proton pump inhibitors (PPIs) is believed to have various potential adverse events. Omeprazole is a part of PPIs most commonly prescribed worldwide; it irreversibly binds to H+-K+ ATPase enzyme system in the gastric parietal cells to reduce secretion of H+ ions into the lumen of stomach. The main objective of the current work is to assess the adverse effects of omeprazole medication on certain haematological and biochemical parameters in patients who were on treatment for one year and more. Methods: We conducted a comparative cross-sectional study between October 2021 and March 2022. A total of 90 participants of both sexes were enrolled in this study, aged between 25-58 years. The participants were categorized into two groups: 40 patients on long-term omeprazole medication (40 mg) as a patients group and 50 healthy subjects as a healthy group who did not use omeprazole. Complete blood count and biochemical parameters were measured for both groups. Results: Patients of a group 1 had remarkable significant reductions in the number of red blood cells (RBCs) (p<0.001) and the indices. Omeprazole elevated the cholesterol level (p<0.001) and triglyceride (p<0.001) as well as low-density lipoprotein (p<0.01). However, no impact was found with high-density lipoprotein (HDL) (p>0.05). Alkaline phosphatase (ALKP) (p<0.001) and aspartate aminotransferase (ASAT) (p<0.01) levels were elevated in long-term patients treated with omeprazole. In contrast, no significant change was found in the level of alanine aminotransferase (ALAT) (p>0.05). Creatinine level (p<0.001) and nitrogen blood urea (p<0.0001) were significantly increased in patients group treated with omeprazole medication. The results also showed that group 1 had a high significant decline in serum ferritin (p<0.0001), vitamin D3 (p<0.01) and calcium levels (p<0.001) than that of healthy group. Conclusion: Prolonged use of omeprazole might result in adverse effect on hematological profile, particularly RBCs and their indices leading to develop anemia in patients on this medication. Furthermore, it might result in disturbances in biochemical profile, levels of minerals and vitamins as consequences of affected absorption.https://actamedindones.org/index.php/ijim/article/view/2231omeprazoleblood counthypocalcemiavitamin dkidney functioncholesteroltriglyceride
spellingShingle Hadeel S. Al Ali
Azza Sajid Jabbar
Nadheerah F. Neamah
Nawal Khalil Ibrahim
Long-Term Use of Omeprazole: Effect on Haematological and Biochemical Parameters
Acta Medica Indonesiana
omeprazole
blood count
hypocalcemia
vitamin d
kidney function
cholesterol
triglyceride
title Long-Term Use of Omeprazole: Effect on Haematological and Biochemical Parameters
title_full Long-Term Use of Omeprazole: Effect on Haematological and Biochemical Parameters
title_fullStr Long-Term Use of Omeprazole: Effect on Haematological and Biochemical Parameters
title_full_unstemmed Long-Term Use of Omeprazole: Effect on Haematological and Biochemical Parameters
title_short Long-Term Use of Omeprazole: Effect on Haematological and Biochemical Parameters
title_sort long term use of omeprazole effect on haematological and biochemical parameters
topic omeprazole
blood count
hypocalcemia
vitamin d
kidney function
cholesterol
triglyceride
url https://actamedindones.org/index.php/ijim/article/view/2231
work_keys_str_mv AT hadeelsalali longtermuseofomeprazoleeffectonhaematologicalandbiochemicalparameters
AT azzasajidjabbar longtermuseofomeprazoleeffectonhaematologicalandbiochemicalparameters
AT nadheerahfneamah longtermuseofomeprazoleeffectonhaematologicalandbiochemicalparameters
AT nawalkhalilibrahim longtermuseofomeprazoleeffectonhaematologicalandbiochemicalparameters